ETF (UCITS compliant)

L&G Healthcare Breakthrough UCITS ETF

Fund facts

Fund size*
$54.9m
Base currency
USD
Listing date
2 Jul 2019
Domicile
Ireland
Index ticker
HTECTR
Replication method
Physical - full replication

Statistics

*As at 21 Oct 2020

Fund aim

The L&G Healthcare Breakthrough UCITS ETF (the "ETF") aims to track the performance of the ROBO Global® Healthcare Technology and Innovation Index TR (the “Index”).

  • Long-term allocation

Long-term megatrend that we believe is radically transforming the way we live and work

  • High growth potential

Aims to capture the outsized growth potential of the healthcare technology industry

  • Leveraging industry expertise

An index tracking investment strategy that is supported by a team of healthcare technology experts

ROBO Global® Healthcare Technology and Innovation Index TR

The Index aims to track the performance of a basket of companies that are actively engaged in the healthcare technology value-chain.

The index is comprised of companies which are publicly traded on various stock exchanges around the world that have a distinct portion of their business and revenue derived from the field of healthcare technologies, and the potential to grow within this space through innovation and/or market adoption of their products and/or services. Companies are included in the index receive a "HTEC Score"  comprised of factors representing (1)the levels of revenue the company receives from innovative healthcare technologies, (2) the levels of investment the firm makes in healthcare technologies, (3) the market and technology leadership of the firm within the universe.

A company is only eligible for inclusion in the Index if it is of a sufficient size (determined by reference to the total market value of its shares) and it is sufficiently "liquid" ( a measure of how actively its shares are traded on a daily basis). Within the Index, companies are weighted according a modified HTEC-factor weighting scheme. The Index is rebalanced quarterly in March, June, September and December.

Index data

Provider
ROBO Global®
Bloomberg code
HTECTR
Reuters code
.HTECTR
Type
Total Return
Website
https://www.roboglobal.com/robo-global-indices/htec-index/

Performance

Source: Lipper.

Performance (%)
Select period:
Change

    Performance summary (%)

    As at 30 Sep 2020

    CumulativeFundBenchmark
    1 month1.371.41
    6 months48.8049.23
    Year to date32.2832.77
    3 years--
    5 years--
    Since launch44.7745.71
    AnnualisedFundBenchmark
    1 year49.0849.88
    3 years--
    5 years--
    Since launch33.8734.55

    As at 30 Sep 2020

    CumulativeFundBenchmark
    Quarterly13.6413.82
    Year to date32.2832.77
    3 years--
    5 years--
    Since launch44.7745.71
    AnnualisedFundBenchmark
    1 year49.0849.88
    3 years--
    5 years--
    Since launch33.8734.55
    Rolling 12-month performance
    Calendar year performance
    Monthly performance
    Annualised performance

    Rolling 12-month performance to last quarter end (%)

    12 months to 30 September 2016 2017 2018 2019 2020
    Fund----49.24
    Benchmark----50.05

    Calendar year performance (%)

    2015 2016 2017 2018 2019
    Fund-----
    Benchmark-----

    Monthly performance (%)

    Annualised performance (%)

    1 year3 years5 yearsSince launch
    Fund49.08--33.87
    Benchmark49.88--34.55

    Annualised performance (%)

    1 year3 years5 yearsSince launch
    Fund49.08--33.87
    Benchmark49.88--34.55

    Performance for the USD Accumulating ETF class in USD, listed on 02 July 2019. Source: Lipper. Performance assumes all ETF charges have been taken and that all income generated by the investments, after deduction of tax, remains in the ETF.

    Past performance is not a guide to the future.

    Portfolio

    As at 30 Sep 2020. All data source LGIM unless otherwise stated. Totals may not sum to 100% due to rounding.

    The breakdowns below relate to the Index. The ETF’s portfolio may deviate from the below

    Sector (%)

    Medical Instruments26.1
    Diagnostics15.0
    Precision Medicine13.3
    Process Automation12.2
    Genomics11.4
    Data Analytics8.2
    Robotics5.2
    Regenerative Medicine4.5
    Telehealth4.2

    Currency (%)

    USD84.4
    EUR6.4
    CHF3.7
    GBP1.6
    HKD1.2
    AUD1.1
    DKK0.9
    JPY0.7
    Top 10 constituents16.5
    Rest of Index83.5
    No. of constituents in Index85

    Top 10 constituents (%)

    Novocure1.9
    Fulgent Genetics1.8
    Exact Sciences1.7
    Quidel1.6
    DiaSorin1.6
    Insulet1.6
    Cardiovascular Systems1.6
    Cellectis1.6
    Natera1.5
    CareDx1.5

    Investment Manager

    GO ETF Solutions LLP is the investment manager for each of the exchange traded funds (ETFs) issued by Legal & General UCITS ETF Plc and is responsible for the day-to-day investment management decisions for this ETF. The team is highly experienced with respect to all aspects relating to the management of an ETF portfolio, including collateral management, OTC swap trading, adherence to UCITS regulations and counterparty exposure and monitoring.

    Literature

    Prices

    Name
    USD Acc
    Currency
    USD
    NAV
    14.85
    Price time
    16:00 EST (NY)

    Further details

    Charges

    TER
    0.49%

    Management / administration

    Issuer
    Legal & General UCITS ETF Plc
    Depositary and Trustee
    The Bank of New York Mellon SA/NV, Dublin Branch
    Securities regulator
    Central Bank of Ireland

    Country registration

    This share class is registered for sale in the following countries:

    Listings

    Details
    Codes
    ExchangeCurrencyTickerListing dateISINBloomberg codeReuters codeTrading hours (local)
    Deutsche BörseEURXMLH10/09/2019IE00BK5BC677XMLH GYDOCT.DE09:00 - 17:30
    London Stock ExchangeGBPDOCG02/07/2019IE00BK5BC677DOCG LNDOCG.L08:00 - 16:30
    London Stock ExchangeUSDDOCT02/07/2019IE00BK5BC677DOCT LNDOCT.L08:00 - 16:30
    Borsa ItalianaEURDOCT10/09/2019IE00BK5BC677DOCT IMLGDOCT.MI09:00 - 17:30
    SIX Swiss ExchangeCHFDOCT05/06/2020IE00BK5BC677DOCT SWDOCT.S09:00 - 17:30

    Key risks

    The value of an investment and any income taken from it is not guaranteed and can go down as well as up. You may not get back the amount you originally invested.

    Past performance is not a guide to the future.

    For more information, please refer to the key investor information document.

    Important information

    Issued by LGIM Managers (Europe) Limited as management company for this fund. Registered in Ireland No. 609677. Registered Office: 33/34 Sir John Rogerson’s Quay, Dublin, 2, Ireland. Authorised and Regulated by the Central Bank of Ireland No. C173733.

    GO ETF Solutions LLP has been appointed as the discretionary investment manager for this Fund, it is authorised and regulated by the Financial Conduct Authority No.477266.

    We are a member of the Irish Funds Association.

    All features described on this website are those current at the time of publication and may be changed in the future. Nothing on this website should be construed as advice and it is therefore not a recommendation to buy or sell securities. If in doubt about the suitability of this product, you should seek professional advice. Copies of the prospectus, key investor information document, annual and semi-annual reports & accounts are available free of charge on request or at www.lgimetf.com.

    This website is only directed at investors resident in jurisdictions where our funds are registered for sale. It is not an offer or invitation to persons outside of those jurisdictions. We reserve the right to reject any applications from outside of such jurisdictions.

    Source and third party data

    Source: Unless otherwise indicated all data contained on this website is sourced from Legal & General Investment Management Limited.

    Where this document contains third party data ('Third Party Data’), we cannot guarantee the accuracy, completeness or reliability of such Third Party Data and accept no responsibility or liability whatsoever in respect of such Third Party Data

    Index disclaimer

    The L&G Healthcare Breakthrough UCITS ETF (the “ETF”) is not sponsored, promoted, sold or supported in any other manner by ROBO Global LLC or Solactive AG (the “Index Parties”), nor do the Index Parties offer any express or implicit guarantee or assurance either with regard to the results of using the ROBO Global® Healthcare Technology and Innovation Index (the “Index”) and/or Index trademark or the Index price at any time or in any other respect. The Index is calculated and published by Solactive AG. The Index Parties use their best efforts to ensure that the Index is calculated correctly. Irrespective of their obligations towards the Company, the Index Parties have no obligation to point out errors in the Index to third parties including but not limited to investors and/or financial intermediaries of the ETF. Neither publication of the Index by Solactive AG nor the licensing of the Index or Index trademark by ROBO Global LLC for the purpose of use in connection with the ETF constitutes a recommendation by the Index Parties to invest capital in the ETF nor does it in any way represent an assurance or opinion of the Index Parties with regard to any investment in the ETF.